Clinical Trial Update: A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial update for Cadonilimab in treatment-naïve or relapsed extensive small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive Small Cell Lung Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Extensive Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN